AQUEOUS FORMULATION COMPRISING TFPI AND SOLUBILIZING AGENTS

Aqueous formulations of TFPI (tissue factor pathway inhibitor) include L-arginine and/or a solubilising agent selected from the group consisting of: an acetate ion; a sulfate ion; sodium chloride; a citrate ion; an isocitrate ion; glycine; glutamate; a succinate ion; histidine; imidazole; sodium dod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GARY V. JOHNSON, BO H. ARVE, MANINDER S. HORA, RAJSHARAN K. RANA, BAO-LU CHEN, HASSAN MADANI, GARY S. BILD, MICHAEL TSANG, MARK E. GUSTAFSON, ROBERT F. HALENBECK, GLENN J. DORIN, KIRK JOHNSON, GREGORY L. PATTISON
Format: Patent
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aqueous formulations of TFPI (tissue factor pathway inhibitor) include L-arginine and/or a solubilising agent selected from the group consisting of: an acetate ion; a sulfate ion; sodium chloride; a citrate ion; an isocitrate ion; glycine; glutamate; a succinate ion; histidine; imidazole; sodium dodecyl sulfate; or a charged polymer. The invention facilitates the solubilization, formulation, purification and refolding of TFPI.